Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 5, 2009, Pages 863-868

  Jakobsen, Carl Johan ^a   Søndergaard, Flemming ^a   Hjortdal, Vibeke E ^a   Johnsen, Søren P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aprotinin; Blood products; Blood transfusion; Mortality; Renal failure; Tranexamic acid

Indexed keywords

APROTININ; CREATININE; TRANEXAMIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS; DRAIN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SIDE EFFECT; STROKE; THROMBOCYTE TRANSFUSION; TRANSFERRIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; APROTININ; BLOOD COMPONENT TRANSFUSION; CARDIAC SURGICAL PROCEDURES; DRUG EVALUATION; EPIDEMIOLOGIC METHODS; FEMALE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RENAL DIALYSIS; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 70350050550     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.05.040     Document Type: Article

References (25)

1. Fergusson D.A., Hébert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., Teoh K., Duke P.C., Arellano R., Blajchman M.A., Bussières J.S., Côté D., Karski J., Martineau R., Robblee J.A., Rodger M., Wells G., Clinch J., and Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
2. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
3. Mangano D.T., Miao Y., Vuylsteke A., Tudor I.C., Juneja R., Filipescu D., Hoeft A., Fontes M.L., Hillel Z., Ott E., Titov T., Dietzel C., and Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. J Am Med Assoc 297 (2007) 471-479
4. Schneeweiss S., Seeger J.D., Landon J., and Walker A.M. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 358 (2008) 771-783
5. Shaw A.D., Stafford-Smith M., White W.D., Phillips-Bute B., Swaminathan M., Milano C., Welsby I.J., Aronson S., Mathew J.P., Peterson E.D., and Newman M.F. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 358 (2008) 784-793
6. Ray W., and Stein M. The aprotinin story-is BART the final chapter?. N Engl J Med 358 (2008) 2398-2400
7. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
8. Henry D.A., Carless P.A., Moxey A.J., O'Connell D., Stokes B.J., McClelland B., Laupacis A., and Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4 (2007) CD001886
9. Pedersen C.B., Gøtzsche H., Møller J.O., and Mortensen P.B. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53 (2006) 441-449
10. Roques F., Nashef S.A.M., Michel P., Gauducheau E., de Vincentiis C., Baudet E., Cortina J., David M., Faichney A., Gabrielle F., Gams E., Harjula A., Jones M.T., Pinna Pintor P., Salamon R., and Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-823
11. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
12. Sørensen H.T. Regional administrative health registries as a resource in clinical epidemiology. Int J Risk Saf Med 10 (1997) 1-22
13. Andreasen J.J., Riis A., Hjortdal V.E., Jørgensen J., Sørensen H.T., and Johnsen S.P. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs 6 (2006) 243-250
14. Rubin D.B. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol 2 (2001) 169-188
15. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004) 702-706
16. Braitman L.E., and Rosenbaum P.R. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 137 (2002) 693-695
17. Austin P.C. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 134 (2007) 1128-1135
18. Stuart E.A. Developing practical recommendations for the use of propensity scores: discussion of 'A critical appraisal of propensity score matching in the medical literature between 1996 and 2003' by Peter Austin, Statistics in Medicine. Stat Med 27 (2008) 2062-2065
19. Normand S.L.T., Landrum M.B., Guadagnoli E., Ayanian J.Z., Ryan T.J., Cleary P.D., and McNeil B.J. Validating recommendations for coronary angiography following an acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
20. Karkouti K., Beattie W.S., Dattilo K.M., McCluskey S.A., Ghannam M., Hamdy A., Wijeysundera D.N., Fedorko L., and Yau T.M. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
21. Pagano D., Howell N.J., Freemantle N., Cunningham D., Bonser R.S., Graham T.R., Mascaro J., Rooney S.J., Wilson I.C., Cramb R., and Keogh B.E. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg 135 (2008) 495-502
22. Bittner H.B., Lemke J., Lange M., Rastan A., and Mohr F.W. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Ann Thorac Surg 85 (2008) 1662-1668
23. Umscheid C.A., Kohl B.A., and Williams K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol 14 (2007) 455-467
24. Furnary A.P., Wu Y.X., Hiratzka L.F., Grunkemeier G.L., and Page III S. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation 116 (2007) I-127-I-133
25. Van der Linden P.J., Hardy J.F., Daper A., Trenchant A., and De Hert S.G. Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome?. Br J Anaesth 99 (2007) 646-652